Key words : diphosphonates, calcium metabolism, bone formation, bone ... of Aubert & Milhaud (1960) and Richelle (1967), which gives an estimate of bone formation ..... weight and ash content in a group of twelve rats aged 54 days was ...
Dec 29, 2015 - To cite this article: Christina L. Ross, Thaleia Teli & Benjamin S. Harrison ... Christina L. Rossa,b, Thaleia Telia, and Benjamin S. Harrisona.
May 13, 2005 - mitogenic effect of adenosine is mimicked by NECA, CCPA, and ... We conclude that adenosine acts as a novel mitogen in porcine CASMC that.
sed melanin content and tyrosinase activity, while a high dose of adenosine resulted in inhibition of tyrosinase ac- tivity. Western blotting showed that adenosine ...
a thermal blanket (#50-7079 Harvard Homeothermic. Blanket System, South Natick, MA) ..... P = NS vs. control). 3.4. Effect of adenosine on myocardial blood jlow during reperfusion. Comparison of regional transmural myocardial blood flow (ischemic cir
ments have identified four adenosine receptor subtypes ... lized with the use of tubocurarine chloride (1 mg/kg iv), and ... rectly dissolved in isotonic saline. Stock solutions of 8SPT, ... was composed of (in meq/l) 156.5 Na , 2.95 K , 2.50 Ca2, ..
After three weeks as a recovery period, 6-OHDA-induced bradykinesia and balance disturbances were ... clinically by tremor, bradykinesia, rigidity and postural.
adenosine receptor mediating the negative dromotropic effect of hypoxia. Oxygen tension and effluent adenosine levels were linearly related with a correlation ...
To further characterize the negative dromotropic effect of adenosine in the guinea ... and deamination of adenosine on its concentration-negative dromotropic ...
500 gav for 90 s. ..... amCA. A log t[PIA] (M)}. Fig. 6. Anti-lipolytic effect of PIA in brown adipocytes from ... Metabolic Functions (Jeanrenaud, B. & Hepp, D., eds.) ...
gic and negative chronotropic and dromotropic prop- erties.1 There are several reports of the use of adenosine as a cardioprotective agent during cardiac.
a negative dromotropic effect, evident electrophysiologi- excitability and refractoriness. In the intact node of the cally as conduction slowing (prolongation of the ...
determined by steady blood pressure and renal blood flow ... warmed to 37Â°C; this sphere solution was injected ... zones which will be designated as zones I-IV, going ... ment of renal function as assessed by examination ... Inc.) was prepared in ca
Adenosine can be metabolized by Rana ridibunda erythrocytes as a carbon source for glycolysis to maintain ATP levels, whereas neither inosine nor glucose ...
increases heart rate by suppressing parasympathetic and augmenting sympathetic components of ... when adenosine is infused in normal humans for clinical.
quadripolar electrode catheters were inserted into a femoral vein ..... Josephson ME. Ctinical Cardiac ... vations by use of simultaneous multisite catheter map-.
inhibition of cell growth, were used to study the effect of adenosine 3'-5'-cyclic monophos- phate (cAMP) on cell proliferation. ... db-cAMP were used exclusively . THE JOURNAL OF CELL BIOLOGY â¢ VOLUME 55, 1972 â¢ pages 1 9-31. 19 ...... LEVINE, E
Council Directive of 24 November 1986 (86/609/EEC). Three- week-old male Wistar ... (mM): sucrose (234), KCl (2.5), NaH2PO4 (1), glucose (11),. MgSO4 (4) ...
Mar 20, 2008 - kinetic analysis of the enzyme activities, decrease in renal Ado levels in hHcys was shown to be associated with inhibition ..... Stryer L. Control of Enzymatic Activity: Biochemistry. ... Kanani PM, Sinkey CA, Browning RL, et al.
of this study is testing adenosine on hyperalgesia after the spinal cord injury. Materials and Methods. Spinal cord mild-compression model (SCI model) and drug ...
leads to P-selectin (CD62P) exposure, which is known to play a fundamental role in the binding of platelets to leukocytes. This gives rise to thrombus formation.
Several epidemiological studies have revealed that garlic consumption is associated with reduced mortality and morbidity15, 16, 33. Some organosulfur compounds like alliin, allicin and s-allyl cysteine have been accepted to play major role in this pr
Docent Peter Raivio. University of ...... visualization of nuclear-stained cells. This method is limited ...... In fact this work was a collaborative team spirit work. Without it, it ..... Stienberg J, Gaur A, Sciacca R, Tan E. New-onset sustained ve
Clinical Science and Molecular Medicine (1916) SO, 413-418.
Effect of diphosphonates on adenosine 3‘:s-cyclicmonophosphate in mouse calvaria after stimulationby parathyroid hormone in vitro U. GEBAUER, R . G . G. RUSSELL, M. TOUABI A N D H. FLEISCH Department of Pathophysiology, University of Berne, Berne, Switzerland
(Received 28 November 1975)
SummarY 1. The diphosphonates, disodium ethane-lhydroxy-1,l-diphosphonate (EHDP) and disodium dichloromethylenediphosphonate (ClzMDP), inhibit bone resorption in animals and in explanted bone in tissue culture. The possibility that these effects might be due to inhibition of skeletal adenylate cyclase has been studied. 2. EHDP and CIzMDP, added for 30 min to the incubation medium at concentrations known to inhibit bone resorption, had no effect on basal content of adenosine 3’: 5‘-cyclic monophosphate (cyclic AMP) of mouse calvaria incubated in vitro, nor did they inhibit therise in cyclic AMP induced by bovine parathyroid hormone. 3. Pretreatment of mice for 3 days with ClaMDP also had no effect on cyclic AMP under basal conditions or after incubation of explanted calvaria with parathyroid hormone in vitro. EHDP under similar conditions slightly inhibited the increase i n d u d by parathyroid hormone but had no effect on basal concentrations of cyclic AMP. 4. It is suggested that the inhibition of adenylate cyclase is not an essential feature of the reduction of bone resorption by diphosphonates, which may act by direct inhibitory effectson the dissolution of hydroxyapatite and perhaps by other unidentified effects on bone cells.
Introduction Parathyroid hormone is known to stirnulate resorption of explants of bone in tissue culture (Gaillard, 1961; Raisz & Niemann, 1969; Raisz, Trummel & Simmons, 1972; Reynolds, Minkin, Morgan, Spycher & Fleisch, 1972) and in intact animals. One of the earlier effects of parathyroid hormone on bone in tissue culture is to produce a rise in bone adenosine 3’: S-cyclic monophosphate (cyclic AMP) content (Chase & Aurbach, 1970; Chase, Fedak & Aurbach, 1969; Aurbach & Chase, 1970; Herrmann-Erlee & Konijn, 1970; Peck, Carpenter, Messinger & DeBra, 1973; Rodan & Rodan, 1974; Smith & Johnston, 1974). Since both N6-2’-0-dibutyryl-3’:5’-cyclic AMP (DAMP), as shown by Vaes (1968), Raisz, Brand, Klein & Au (1969), Heersche, Fedak & Aurbach (1971), Herrmann-Erlee & van der Meer (1974), and cyclic AMP” can stimulate resorption in bone explants in culture, it has been suggested that parathyroid hormone may act on bone by causing changes in cyclic AMP content in bone cells. Diphosphonates, such as ethane-1-hydroxy-1,ldiphosphonate (EHDP), and dichloromthylene diphosphonate (CLMDP), inhibit bone resorption both in tissue culture (Russell, Miihlbauer, Bisaz,
Correspondence: Dr U. Gebauer, Department of Pathophysiology, University of Berne, Murtenstrasse 35, CH-3010 b e , Switzerland.
Williams & Fleisch, 1970; Reynolds etal., 1972; Reynolds, Murphy, Miihlbauer, Morgan & Fleisch, 1973; Minkin, Rabadjija & Goldhaber, 1974) arid in experimental animals (Schenk, Merz, Miihlbauer, Russell & Fleisch, 1973; Gasser, Morgan, Fleisch & Richelle, 1972). EHDP has been used in man to reduce excessive bone turnover, notably in Paget’s disease (Russell, Smith, Preston, Walton & Woods, 1974; Guncaga, Lauffenberger, Lentner, Dambacher, Haas, Fleisch & Olah, 1974; Altman, Johnston & Khairi, 1973). Although the effects of diphosphonates on bone resorption have been thought to be due to inhibition of dissolution of apatite crystals, an effect which can be demonstrated readily on synthetic crystals in vitro (Fleisch, Russell & Francis, 1969), it is possible that other mechanisms may be involved. Diphosphonates closely resemble inorganic pyrophosphate (PP1), a product of the adenylate cyclase reaction, and it is possible therefore that they may interfere with production of cyclic AMP. Pilczyk, Sutcliffe & Martin (1972) have shown that both diphosphonates and PPI can reduce adenylate cyclase activity stimulated by fluoride or parathyroid hormone in a kidney-cellmembrane preparation. Inhibition of fluoride- and glucagon-stimulated adenylate cyclase in isolated liver membranes has also been demonstrated (Eisman, Martin, Pilczyk, Legge & Sutcliffe, 1974). In order to determine whether diphosphonates might act on bone by inhibiting adenylate cyclase we have examined the influence of diphosphonates given in vitro or in vivo on cyclic AMP content in mouse calvaria before and after stimulation by parathyroid hormone.
Materials and methods Four-day-old mice from an NMRI strain bred in this Department were killed by decapitation. The calvaria were dissected out under a binocular microscope into Tyrode’s solution containing 2-(N-2hydroxyethylpiperazin-N-y1)ethanesulphonic acid (HEPES buffer; 2.5 mmol/l) and bovine serum albumin (2.5 g/l), with a total osmolarity of 320 mosmol/l. Care was taken not to damage the periosteum during dissection. The calvaria, consisting of frontal and parietal bones, were divided in half and each half was dried on a paper towel and weighed on a Cahn Electrobalance. Immediately after, the halves were put back into the Tyrode-Hepes buffer-albumin solution and kept at room temperature until incubation.
After time-courses and dose-response curves to parathyroid hormone had been established, three groups of experiments were performed. Experiment 1. One half of each calvaria was preincubated for 30 min at 37°C in Technicon Autoanalyzer sample cups containing 1 ml of the TyrodeHepes buffer-albumin solution (control half), and the other half in 1 ml of the same solution plus different amounts of either CLMDP or EHDP (treated half). After this 30 rnin preincubation, paired halves of these calvaria were incubated for a further 5 min either in a solution containing parathyroid hormone (5 unitsiml) or in Tyrode-Hepes buffer-albumin without hormone. Both solutions contained no diphosphonates during the 5 min incubation. Experiment 2. Calvariawere preincubatedas above, but instead of the medium being changed after 30 min, parathyroid hormone was added for a further 5 min at a concentration of 5 unitslml, so that, in contrast to experiment 1, the diphosphonates were still present during the 5 rnin exposure to parathyroid hormone. Experiment 3. Since it was possible that a preincubation time of 30 min was insufficient to allow the diphosphonates to be taken up by the bone, further experimentswere done by injecting the diphosphonates subcutaneously into newborn mice. On each of 3 days, the animals received 161 pmolikg daily of either Cl+MDP or EHDP dissolved in, 50 pl of NaCl solution (165 mmol/l). The control animals received only the NaCl solution. On the fourth day, the calvaria were removed and incubated for 5 rnin without the 30 min preincubation. Onehalf of each calvaria was exposed to parathyroid hormone (5 unitslml) and the other to Tyrode Hepes buffer-albumin solution alone. Under these conditions, in which diphosphonates are given to living newborn mice, it is known that bone resorption during subsequent incubation in uitro is markedly inhibited (Reynolds & Morgan, 1970). After incubation, the calvaria were placed immediately into liquid nitrogen. The frozen pieces were homogenized with 1 ml of trichloroacetic acid (50 gll) in a Dual glass homogenizer and the homogenates centrifuged at 12OOO g for 5 min. The supernatant was extracted three times with twice its volume of ether saturated with water and then assayed for cyclic AMP by a protein-binding method (Gilman, 1970). Phosphodiesterase added to the etherextracted supernatant resulted in complete loss of measurable cyclic AMP. The binding curve, plotted
Diphosphonates and cyclic AMP in bone in vitro
as l/c.p.m. against l/concentration, gave a straight line. The binding protein for cyclic AMP and the inhibitor protein were both prepared from bovine skeletal muscle by the method of Gilman (1970).
Materials Parathyroid hormone was partially purified native bovine parathyroid hormone (600 unitslmg; Wilson Laboratories, Chicago, Ill., U.S.A.); Hepes buffer was from Serva (Heidelberg, Germany); bovine serum albumin (purified) was from Merck (Darmstadt, Germany); 8-i3H]-adenosine3': 5'cyclic phosphate, ammonium salt (22.1 Cilmmol), was from New England Nuclear Corp.; adenosine 3':5'-cyclic monophosphonic acid was from Sigma (St Louis, Mo.,U.S.A.).The diphosphonates were kindly provided as their disodium salts by the Procter and Gamble Co. (Cincinnati, Ohio, U.S.A.). All other reagents used were of highest obtainable Purity.
0.5 2 5 1 0 Pwthyrdd hormone b i t s / ml I
FIG.1. Cyclic A M P content of mouse calvaria after 5 min incubation with various concentrations of bovine parathyroid hormone in v i m . Each point represents the mean value f 2 SB)~Iof five incubations.
Results Response to parathyroid hormone A significant, approximately threefold increase in cyclic AMP content of the calvaria was obtained after adding parathyroid hormone to the medium. It was found that the maximum concentration of cyclic AMP was reached after 5 min incubation with
the hormone so this incubation time of 5 min was chosen for further experiments. Fig. 1 shows the dose-response curve for parathyroid hormone with an incubation time of 5 min. A signscant but submaximalstimulation was always
To 5 0
F $ -
2 30 a
5._ 20 0
CIzMDP IfifiWl/ I )
FIG.2. Effect of C1,MDP and EHDP on cyclic AMP content of calvaria incubated with and without parathyroid hormone. The stippled columns represent basal levels obtained after incubation in TyroQHepes buffer-albumin solution alone, and the open columns represent the values obtained in the presence of parathyroid hormone (5 units/ml). In these experiments the diphosphonates were prasmt with the calvaria for 30 min pmincubation, but were not present during the subsequent 5 min incubation with or without parathyroid hormone. Each column shows the mean value & 2 SEEMof five incubations. D
U.Gebauer et al.
obtained with 5 units/ml. This concentration, rather than 10 unitslml which produced a maximum response, was used in subsequent experiments, so that the conditions would be at their most sensitive for detecting stimulation or inhibition by diphosphonates. Effect of diphosphonates added in vitro Fig. 2 shows that 30 rnin preincubation with C1,MDP at concentrations of 8.1, 65 or 516 pmolll had no effect on basal cyclic AMP content of the calvaria or on the rise induced by parathyroid hormone. Fig. 2 also showsthat EHDP, added at the highest concentration of 516 pmol/l, had no effect on basal content of cyclic AMP or on the increase induced by parathyroid hormone. In our hands these concentrations also inhibit bone resorption of calvaria in uitro. Thus addition of C12MDP (65 pmol/l) to the tissue culture medium for 2 days inhibits resorption by 35% and addition of C12MDP at 516 pmol/l by 48%. The addition of EHDP at 516 pmol/l similarly inhibits the resorption by 37%. Fig. 3 shows that when diphosphonates were present both during the preincubation (30min) and the final 5 min incubation period there was again no effect of either of the diphosphonates at a concen70
CIzMDP (firnot /I1
Fm. 3. Effect of C1,MDP and EHDP at 516 pmolll on basal and parathyroid hormone-stimulated content of cyclic AMP in calvaria incubated in vitro. In these experiments (mean value +_2SEM of five incubations) the diphosphonates were present during both the preincubation (30 min) and the final 5 rnin incubation period with (open and stippled columns) or without (cross-hatched columns) parathyroid hormone.
FIG.4. Effect of pretreatment of mice by subcutaneous injection of 161 pmol of EHDP or of ClpMDP/kg daily on the basal and parathyroid hormone-stimulated content of cyclic AMP in calvaria incubated (5 min) in vitro. Control mice were injected with sodium chloride solution. Each column shows the mean value k2 SEM of six incubations: stippled columns, without parathyroid hormone; open columns. with parathyroid hormone.
tration of 516 nmol/ml on the production of cyclic AMP under basal conditions or after stimulation by parathyroid hormone. Effect of diphosphonates given to mice in vivo Fig. 4 shows that neither C12MDP nor EHDP given subcutaneously for 3 days to mice had an effect on cyclic AMP content of the calvaria when the bones were incubated in uitro for 5 min in control buffer after explantation. When parathyroid hormone was added to the buffer the usual rise in content of cyclic AMP occurred but was slightly but not significantly less than normal (Student’s t-test, P>O.O5) in the calvaria from mice injected with EHDP.
Discussion The basal amounts of cyclic AMP and the response to parathyroid hormone closely resemble those d e scribed by Chase et al. (1969). Neither of the diphosphonates, EHDP and C12MDP, when added to calvaria in uitro or previously injected into mice, had any effect on basal content of cyclic AMP or on this response to parathyroid hormone. The only exception to this was the slight but not significant impairment of the response to the hormone in calvaria from mice treated with EHDP in vivo. The concentrations of diphosphonates used in vitro and in vivo were the
Diphosphonates and cyclic AMP in bone in vitro
same as those previously found to inhibit bone resorption either when added in tissue culture or when injected into newborn mice. At the dose of EHDP at which some inhibition of parathyroid hormone-stimulated adenylatecyclase activity occurred, resorption is known to be blocked completely (Reynolds et al., 1972). However, CLMDP, which inhibits resorption more strongly than EHDP, had no effect on content of cyclic AMP in any of the experiments.These experiments show that the inhibition by diphosphonates of resorption induced by parathyroid hormone is unlikely to be due to inhibition of skeletal adenylate cyclase. These results are in contrast with those of DeLong, Feinblatt & Rasmussen (1971), who showed that high doses of PP, infused into rats inhibited bone resorption and at the same time inhibited renal production of cyclic AMP. Furthermore, filayk et al. (1972) and Eisman et al. (1974) have demonstrated inhibition by diphosphonates of renal and liver adenylate cyclase responses to parathyroid hormone and glucagon respectively. The lowest concentrations required to produce some inhibition were 2.5 pmol/l,although maximal inhibitionrequired doses in the range 0-1-1.0 mmol/l. This corresponds to the highest concentrations of 0.516 mmol/l used here, which are capable of inhibiting bone resorption almost completely but have no effecton content of cyclic AMP. The experiments of Eisman et al. (1974) were done on isolated plasma membranes rather than on an intact tissue as in the present experiments. Broken-cell preparations may be more sensitive to inhibition by diphosphonates; it is possible that inhibition in intact cells would require uptake of diphosphonates by cells, and it is not known whether this occurs. The concentration of phosphonates around bone cells is probably not the same as those added to the medium because of adsorption by hydroxyapatite crystals. It is possible also that there may be differences in the sensitivity of the cyclases from different tissues. However, even with kidney adenylate cyclase, it appears that in humans the increase in urinary cyclic AMP and in phosphate clearance induced by parathyroid hormone is unaltered by prior treatment with EHDP (Recker, Hassing, Lau & Saville, 1973). It could be argued that the response to parathyroid hormone might have been impaired if the diphosphonates had been given for longer or if the effect of the hormone had been measured at another time, particularly since the cyclic AMP response is transient and occurs a long time before increased bone
resorption takes place. Furthermore the calvaria contain several different types of cell, and it is possible that their response may vary in such a way that, although no overall change in cyclic AMP takes place, there may be cwithin particular cell populations. Indeed, studies on isolated bone cells show that parathyroid hormone increasescyclic AMP content in cell populations unlikely to contain many osteoclasts (Peck et al., 1973) and that the effect varies according to the site from which the cells are derived (Smith & Johnston, 1974; Wong & Cohn, 1975). The role of cyclic AMP in parathyroid hormone-mediated resorption is still unclear, especially since other agents (e.g. 1,25-dihydroxycholecalciferol, unpublished results, and vitamin A and 25-hydroxycholecalciferol) which promote bone resorption can do so without causing a detectable increase in cyclic AMP (Mahgoub & Sheppard, 1975). Moreover, calcitonin, which inhibits bone resorption, potentiates rather than inhibits the action of parathyroid hormone on adenylate cyclase, perhaps because it acts on a separate cell population (Wong 8c cohn,1975). It is possible that the changes in cyclic AMP in response to hormone are related to the control of cell division (Burger, Bombik, Breckenridge & Sheppard, 1972; Otten, Johnson & Pastan, 1971) rather than to the stimulation of the resorption process itself. Therefore these results show that the inhibition of parathyroid hormoneinduced bone resorption by EHDP and CLMDP does not induce an early inhibition of the adenylate cyclase reaction. It is nevertheless possible that the diphosphonates inhibit bone resorption by an independent action on cells. There are changes in osteoclast morphology and matrix biosynthesis (Minkin et al., 1974; Schenk et al., 1973; Doty, Jones & Finerman, 1972) under the diphosphonates but it is impossibleto know whether these are direct effects or changes brought about indirectly, for example, by changing the local ionic environment as a result of inhibition of apatite dissolution.
Acknowledgments This work has been supported by the Swiss National Foundation for Scientific Research (KF 6 and 3.121.73), by the US Public Health Service (AM07266), and by the Procter and Gamble &., U.S.A.
and laboratory manifestations of Paget’s disease (osteitis deformans). New England Journal of Medicine, 289, 1379-1 384. AURBACH, G.D. & CHASE, L.R. (1970) Cyclic 3’:5’-adenylic acid in bone and the mechanism of action of parathyroid hormone. Federation Proceedings, 29, 1179-1 182. BURGER,M.M., BOMBIK, B.M., BRECKENRIDGE, B.McL. & SHEPPARD, J.R. (1972) Growth control andcyclic alterations of cyclic AMP in the cell cycle. Nature: New Biology, 239, 161-163. CHASE,L.R. & AURBACH, G.D. (1970) The effect of parathyroid hormone on the concentration of adenosine 3’: 5’-monophosphate in skeletal tissue in vitro. Journal of Biological Chemistry, 245, 1520-1526. CHASE,L.R., FEDAK, S.A. & AURBACH, G.D. (1969) Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology, 84, 761-768. DELONG,A., FEINELATT, J. & RASMUSSEN, H. (1971) The effect of pyrophosphate infusion on the response of the thyroparathyroidectomized rat to parathyroid hormone and adenosine-3’: 5’-cyclic monophosphate. Calcified Tissue Research, 8, 87-95. DOTY,S.B., JONES,R. & FINERMAN, G.A. (1972) Diphosphonate influence on bone cell structure and lysosomal activity. Journal of Bone and Joint Surgery, 55A, 1128-1 129. EISMAN,J.A., MARTIN,T.J., PILCZYK,R., LEGGE,D.G. & SUTCLIFFE, H.S. (1974) Influence of pyrophosphate and diphosphonates on rat liver adenylate cyclase. Clinical and Experimental Pharmacology and Physiology, 1,13-21. FLEISCH, H., RUSSELL,R.G.G. & FRANCIS, M.D. (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science, 165, 1262-1264. GAILLARD, P.J. (1961) In: The Parathyroids, pp. 2045. Ed. Green R.O. & Talmage, R.V. Thomas, Sprinpfield, Ill. GASSER, .A.B., MoRGAN,-D.B.,FLEISCH, H.A. & RICHELLE, L.J. (1972) The influence of two diphosphonates on calcium metabolism in the rat. Clinical Science, 43, 3145. GILMAN,A.G. (1970) A protein-binding assay for adenosine 3’: 5‘-cyclic monophosphate. Proceedings of the National Academy of Sciences of the United States of America, 67, 305-3 12. GUNCAGA, J., LAUFFENBURGER, TH., LENTNER, CH., DAMBACHER, M.A., HAAS, H.G., FLEISCH,H. & OLAH,A.J. (1974) Diphosphonate treatment of Paget’s disease of bone. A correlated metabolic, calcium kinetic and morphometric study. Hormones and Metabolism Research, 6, 62-69. HEERSCHE, J.N.M., FEDAK, S. & AURBACH, G.D. (1971) The mode of action of dibutyryl adenosine 3’: 5’-monophosphate on bone tissue in vitro. Journal of Biological Chemistry, 246, 6770-6775. HERRMANN-ERLEE, M.P.M. & KONIJN,T.M. (1970) Effect of parathyroid extract on cyclic AMP content of embryonic mouse calvaria. Nature (London), 227, 177-178. HERRMANN-ERLEE, M.P.M. & VAN DER MEER,J.M. (1974) The effects of dibutyryl cyclic AMP, aminophylline and propranolol on PTE-induced bone resorption in vitro. Endocrinology. 94, 424-434. MAHGOUB, A. & SHEPPARD, H. (1975) Early effect of 25hydroxycholecalciferol (25-OH-Da) and 1,25-dihydroxycholecalciferol (1,25-(OH)zD3) on the ability of parathyroid hormone (PTH) to elevate cyclic AMP of intact bone cells. Biochemical and Biophysical Research Communications, 62, 901-907. MINKIN,c., RABADIIJA, L. & GOLDHABER, P. (1974) Bone remodelling in vitro: the effects of two diphosphonates on osteoid synthesis and bone resorption in mouse calvaria. Calcified Tissue Research, 14, 161-168. OTTEN,J., JOHNSON, G.S. & PASTAN, I. (1971) Cyclic AMPlevels in fibroblasts: relationships to growth rate and con-
tact inhibition of growth. Biochemical and Biophysical Research Communications, 44, 1192-1 198. PECK,W.A., CARPENTER, J., MESINGER, K. & DEBRA,D. (1973) Cyclic 3’: 5’-adenosine monophosphate in isolated bone cells: Response to low concentrations of parathyroid hormone. Endocrinology, 92, 692-697. PILCZYK, R., SUTCLIFFE, H. & MARTIN, T.J. (1972) Effects of pyrophosphate and diphosphonates on parathyroid horm o n e and fluoridestimulated adenylate cyclase activity. FEBSLetters, 24, 225-228. RAISZ,L.G., BRAND,J.S., KLBIN,D.C. & Au, W. (1969) In: Progress in Endocrinology, pp. 696-703. Ed. Gual, C. & Ebling, F.J.G. Excerpta Medica Foundation, Amsterdam. RAISZ,L.G. & NIEMANN, I. (1969) Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology, 85,446452. RAISZ, L.G., TRUMMEL, C.L. & SIMMONS, H. (1972) Induction of bone resorption in tissue culture: prolonged response after brief exposure to parathyroid hormone or 25hydroxycholecalciferol.Endocrinology, 90, 744-75 1. RECKER, R.R., HASSING, G.S., LAW,J.R. & SAVILLE, P.D. (1973) The hyperphosphatemic effect of disodium ethane1-hydroxy-1,l-diphosphonate(EHDPTM): renal handling of phosphorus and the renal response to parathyroid hormone. Journal of Laboratory and CIinical Medicine, 81, 258-266. REYNOLDS, J.J., MINKIN,C., MORGAN, D.B., SPYCHER, D. & FLEISCH, H. (1972) The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calcified Tissue Research, 10, 302-313. REYNOLDS, J.J. & MORGAN, D.B. (1970) A combined in vivo and in vitro study of the effects of diphosphonates on bone resorption. Journal of Bone and Joint Surgery, 52B, 796-797. REYNOLDS, J.J., MURPHY,H., MOHLBAUER, R.C., MORGAN, H. (1973) Inhibition by diphosphonates of D.B. & FLEISCH, bone resorption in mice and comparison with grey-lethal osteopetrosis. Calcified Tissue Research, 12, 59-71. RODAN,S.B. & RODAN,G.A. (1974) The effect of parathyroid hormone and thyrocalcitonin on the accumulation of cyclic adenosine 3’: 5’-monophosphate in freshly isolated bone cells. Journal of Biological Chemistry, 249,3068-3074. RUSSELL, R.G.G., MUHLBAUER, R.C., BISAZ,S., WILLIAMS, D.A. & FLEISCH, H. (1970) The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomized rats. Calcified Tissue Research, 6, 183-196. RUSSELL, R.G.G., SMITH,R., PRESTON, C., WALTON, R.J. & WOODS,C.G. (1974) Diphosphonates in Paget’s disease. Lancet, i, 894-898. SCHENK,R., MERZ. W.A., M~~HLBAUER, R.C., RUSSELL, R.G.G. & FLEISCH. H. (1973) Effect of ethanel-hydroxy1,I-diphosphonate (EHDP) and dichloromethylenediphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibia1 epiphysis and metaphysis of rats. Calcified Tissue Research, 11, 196-214. SMITH,D.M. &JOHNSTON, C.C., JR (1974) Hormonal responsiveness of adenylate cyclase activity from separated bone cells. Endocrinology, 95, 130-139. VAES,G. (1968) Parathyroid hormone-like action of N6-2‘-0dibutyryladenosine-3’:5‘ (cyclic)-monophosphate on bone explants in tissue culture. Nature (London),219,939-940. WONG,G.L. & C o m , D.V. (1975) Target cells in bone for parathormone and calcitonin are different: Enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proceedings of the National Academy of Sciences of the United States of America, 72, 3 167-3 171,